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Abstract 
Introduction: In older men, sexual disorders may be the result of a decrease in testosterone and an increase in sex hormone binding 
globulin (SHBG) serum levels. Although obesity may enhance the decline of testosterone, it is also the cause of metabolic disorders, which 
are additional risk factors of erectile dysfunction. The purpose of this study was to investigate whether elevated body weight is associated 
with decreased serum testosterone concentrations and reduced sexual function in young men.
Material and methods: Data on general health, medication, depressive symptomatology and sexual life was obtained from 136 men aged 
20–49 years. Blood levels of LH, total testosterone (TT), dehydroepiandrosterone sulfate (DHEA-S), oestradiol, SHBG, total cholesterol, 
LDL- and HDL-cholesterol, and triglycerides were determined. Body mass index (BMI), waist to hip ratio (WHR) and free testosterone 
index (FTI) were calculated. 
Results: A significantly reduced occurrence of sexual fantasies, morning erections and erectile function scores was observed in the oldest 
group compared to the youngest men with normal BMI, although orgasmic function was unchanged. A significant decrease in TT serum 
levels was observed in obese 30-year-olds compared to men with normal BMI, while in obese 40-year-olds decreased LH and SHBG levels 
were also found. No differences in the levels of lipids and sexual achievements were found among men with different BMI. However, 
erectile function and morning erections significantly negatively correlated with age, BMI and WHR, and positively with FTI, but not with 
other studied hormones and lipids.
Conclusions: In young men, obesity can lead to a deterioration of erectile function as a result of lower testosterone levels as the only 
reason. (Endokrynol Pol 2014; 65 (3): 203–209)
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Streszczenie
Wstęp: U starszych mężczyzn zaburzenia seksualne mogą być następstwem zmniejszania się stężenia testosteronu i wzrostu stężenia 
globuliny wiążącej steroidy płciowe (SHBG) we krwi. Otyłość może nasilać obniżanie stężenia testosteronu, ale jest także przyczyną za-
burzeń metabolicznych, które stanowią dodatkowe ryzyko pojawienia się zaburzeń erekcji. Celem pracy było zbadanie, czy nadmierna 
masa ciała jest związana z obniżonym stężeniem testosteronu i pogorszeniem funkcji seksualnych już u młodych mężczyzn. 
Materiał i metody: Dane na temat stanu zdrowia, stosowanych leków, objawów depresji i życia seksualnego uzyskano od 136 mężczyzn 
w wieku 20–49 lat. We krwi oznaczono stężenia LH, testosteronu całkowitego (TT), siarczanu dehydroepiandrosteronu (DHEA-S), estra-
diolu, SHBG, cholesterolu całkowitego, cholesterolu LDL i HDL oraz triglicerydów. Wyliczono wskaźniki: masy ciała (BMI), talia/biodra 
(WHR) i wolnego testosteronu (FTI).
Wyniki: Znamienne zmniejszenie częstości fantazji seksualnych i porannych erekcji oraz pogorszenie jakości erekcji, ale nie zdolności 
do osiągania orgazmu, obserwowano w najstarszej grupie badanych w porównaniu z grupą najmłodszych mężczyzn z prawidłowym 
BMI. Znamienne zmniejszenie stężenia TT stwierdzono u otyłych 30-latków w porównaniu z mężczyznami z prawidłowym BMI, 
a u 40-latków dodatkowo stwierdzono zmniejszenie stężenia LH i SHBG. Nie stwierdzono znamiennych różnic w stężeniu lipidów, 
a także w jakości reakcji seksualnych u mężczyzn z różnym BMI. Jednakże, jakość erekcji oraz częstość występowania porannych erekcji 
znamiennie negatywnie korelowały z wiekiem, BMI i WHR, a pozytywnie z FTI, ale nie z innymi badanymi hormonami i lipidami.
Wnioski: U młodych mężczyzn otyłość może prowadzić do pogorszenia erekcji na skutek obniżenia stężenia testosteronu jako jedynej 
przyczyny. (Endokrynol Pol 2014; 65 (3): 203–209)
Słowa kluczowe: mężczyźni; funkcje seksualne; testosteron; zaburzenia wzwodu; otyłość
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Introduction
The incidence of obesity has increased dramatically 
over the last 30 years, especially in highly industrialised 
countries, where the lifestyle commonly includes a high 
calorie diet and low physical activity. A progressive de-
cline of the age threshold of subjects with overweight 
and obesity has been observed. In the age group under 
18 years, the prevalence of excessive body weight tri-
pled in the last decade of the 20th century and now in 
Europe constitutes 16–22% [1]. In men, the frequency 
of obesity in the European population is approximately 
15% [2]. The European Male Ageing Study (EMAS) re-
vealed the prevalence of obesity among 2,736 men aged 
40–70 years to be 24% [3]. In turn, our previous study 
revealed that as many as 50% of young men (20–39 years 
old) had excessive body weight: 36% were overweight 
and 14% were obese [4]. 
Links between obesity and cardiovascular artery 
disease, hypertension and diabetes mellitus are well 
documented in both sexes [5–7]. Obesity in men has also 
been shown to be associated with low plasma testoster-
one concentrations and erectile dysfunction (ED) [8, 9]. 
Decreased testosterone level and visceral adipose tissue 
accumulation in the ageing male probably represent the 
most important factors for comorbidities and mortality 
from cardiovascular disease [10, 11]. Hypoandrogenism 
in men is manifested, among other things, by a lack of 
interest in sex (no sexual fantasies), lack of spontaneous, 
morning erections, ED during sexual stimulation and 
difficulty in achieving orgasm [12, 13]. EMAS revealed 
that among men above 40, those with the lowest levels 
of total and free testosterone reported significantly 
lower sexual function compared to men with the 
highest testosterone levels [14]. Androgen deficiency 
in older men creates a clinical syndrome called late 
onset hypogonadism (LOH), which is associated with 
multiple end-organ deficits [15]. However, as this deficit 
of testicular function is not yet present in young men, 
the direct effect of obesity on androgen action may be 
clearly visible. 
The purpose of this study was to investigate wheth-
er elevated body weight is associated with decreased 
serum testosterone concentrations and lower sexual 
function already present in younger men.
Material and methods
Subjects and Study Design
The study was performed after the approval of the 
Bioethical Committee of the Medical University of Lodz, 
Poland. A group of 300 men was randomly recruited 
from the Lodz city population register. The only crite-
rion for selection was for the subject to be aged between 
20–49 years. Subjects were invited by a letter to attend 
a screening visit at the Department of Andrology and 
Reproductive Endocrinology, Medical University of 
Lodz. The overall response rate for participation was 
46%. Men who agreed to participate in the study (136 
subjects, mean age 35.5 ± 10 years) were divided into 
age bands: 20–29 (44 subjects), 30-39 (36 subjects) and 
40–49 (56 subjects).
Anthropometry
Body weight and height, waist and hip circumference 
were measured using standard procedures. Calculated 
were body mass index (BMI = weight [kg]/height2 [m]) 
and waist to hip ratio (WHR) [cm]. Each age band was 
divided according to BMI into a group with normal 
weight (18.5–24.9 kg/m2), overweight (≥ 25.0–29.9 kg/m2) 
and obesity (> 30.0 kg/m2). 
Hormone and lipid measurements
Single venous blood samples were taken in the morn-
ing hours (8.00–10.00) in a fasting state, 12 hours after 
the last meal. Serum was separated and stored at –80oC 
until assayed at the end of the study, not longer than 
six months. 
Serum determinations of luteinising hormone (LH, 
normal range: 1.2–10.0 IU/L), total testosterone (TT, 
normal range: 7.5–28.2 nmol/L), dehydroepiandroster-
one sulfate (DHEA-S normal range: 30.0–333.0 µg/dL), 
oestradiol (normal range: 19.7–242.0 pmol/L), and 
sex hormone binding globulin (SHBG, normal range: 
13.0–71.0 nmol/L) were performed. All hormones were 
measured using chemiluminescence immunoassay 
(Immulite 1000, DPC, USA). Detection limits were for: 
LH — 0.1 IU/L, TT — 0.5 nmol/L, DHEA-S — 3 µg/dL, 
oestradiol — 20 pmol/L, and SHBG — 0.2 nmol/L. Free 
testosterone index (FTI) was calculated as follows: total 
testosterone [nmol/L]/SHBG [nmol/L] × 100.
Serum levels of total cholesterol (TC, normal range: 
3.0–5.2 mmol/l), LDL-cholesterol (LDL-C, normal range: 
< 2.6 mmol/L), HDL-cholesterol (HDL-C, normal 
range: > 1.0 mmol/L), triglycerides (TG, normal range: 
< 1.7 mmol/L), and glucose (normal range: 3.3–5.5 
mmol/L) were determined with the use of enzymatic 
methods (Cobas Integra 800, Roche Diagnostics, Poland).
Questionnaires 
Subjects were asked to complete an interviewer-assisted 
questionnaire gathering information on general health, 
medications and lifestyle. General health was scored 
from 0, when very good, to 3, when very bad. To meas-
ure depressive symptomatology, the Beck Depression 
Inventory II (BDI-II) questionnaire was used [16]. 
To evaluate the quality of the sex life of the subject, 
a separate unassisted questionnaire was completed. 
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This questionnaire was validated and used as a scientific 
tool in the EMAS study in which we participated [17]. 
The questionnaire comprised a set of multiple choice 
questions. Questions concerning the previous four weeks 
were as follows: 1) Do you have a sexual partner? (An-
swer: yes, no); 2) Are you able to achieve and maintain 
an erection sufficient for sexual intercourse? (Answer: 
never, almost never, sometimes, usually, almost always/ 
/always; score 1–5); 3) How often do you reach orgasm 
during sexual stimulation? (Answer: never, almost never, 
sometimes, usually, almost always/always; score 1–5); 
4) How often do you wake up with an erection? (An-
swer: never, 1 time/month, 2–3 times/month, 1 time/ 
/week, 2–3 times/week, 4–6 times/week, 1 time/day, 
> 1 time/day; score 0–7); and 5) How often do you think 
about sex (sexual fantasies)? (Answer: never, 1 time/ 
/month, 2–3 times/month, 1 time/week, 2–3 times/week, 
4–6 times/week, 1 time/day, > 1 time /day; score 0–7). 
Statistical analysis
All statistical analyses were performed using Statistica 
for Windows PL software, version 10.0 (Statsoft Inc., 
Tulsa, OK, USA). Mean ± standard deviations (SD) were 
used to express group data. The ANOVA Kruskal-Wallis 
test was applied for the comparison of nonparametric 
variables between groups, after the distribution of val-
ues had been verified by the Shapiro-Wilk test. Correla-
tions were examined using Spearman’s rank correlation 
analysis. P < 0.05 was considered significant.
Results
One or more morbidities were reported by 16 men. The 
most frequent were gastrointestinal ulcer (50%) and 
hypertension (37.5%). General health was significantly 
worse in men aged 40–49 (score 2.0 ± 1.3; p < 0.001) 
compared to younger ones (score for 20-year-olds: 
1.1 ± 1.5; score for 30-year-olds: 1.8 ± 1.5). BDI-II re-
vealed that one 20-year-old man presented symptoms 
of severe depression and four men aged 40 presented 
with moderate depression. All of them reported adverse 
life events during the previous weeks. Total scoring of 
BDI-II was not related to age, general health scoring, 
blood lipids and sex hormones serum levels. Details on 
general health and BDI-II are presented in our previous 
study on the same group of men presented by Kramek 
et al. [18]. Nobody used antidepressants, psychotropic 
drugs, narcotics, lipid-lowering medications or anti-
androgens. None was denoted as an alcoholic or drug 
addict. A total of 62.5% of men were current or former 
smokers (20-year-olds — 52.3%, 30-year-olds — 63.9%, 
40-year-olds — 65.2%). None used a special diet. 
In the whole group, 38.8% of people led a seden-
tary life and did not show any other physical activity. 
Among professional working men, 74.4% had jobs that 
involved sitting. 
Results of hormonal determinations and serum lev-
els of lipids in men between 20 and 49 years of age with 
different BMI values are shown in Table I. Among men 
with a normal BMI, a significant increase in LH, SHBG 
and all lipid serum levels was observed in 40-year-olds 
compared to 20-year-olds. A significant decrease of FTI 
and DHEA-S, but not TT serum level, was visible in men 
30 and above. It was also shown that oestradiol serum 
level is significantly lower in 40-year-old men.
In obese men, a significant decrease in TT serum 
levels was found in 30-year-olds compared to men with 
normal BMI, while decreased LH and SHBG levels were 
also found in 40-year-olds with higher BMI. A trend 
towards increased oestradiol and DHEA-S with grow-
ing weight was visible, but not statistically significant. 
No differences were found in the levels of lipids among 
men with different BMI values.
A total of 18% of 20-year-olds, 8% of 30-year-olds 
and 2% of 40-year-old men reported a lack of sexual 
partner. Nobody reported severe dysfunction of erec-
tion or orgasm i.e. achievement “never” or “almost 
never”. Table II shows the results of the sex life assess-
ment and their comparisons between age groups and 
between men with different BMI scores. Less frequent 
sexual fantasies, reduced erectile function, and lower 
morning erection scores were observed in the oldest 
group compared to the youngest men, although orgas-
mic function was unchanged. No significant differences 
were found between men with different BMI values in 
each age group. 
The correlations between age, FTI, and sexual fan-
tasy, erectile function and morning erection results are 
presented in Table III. Erectile function and morning 
erections significantly negatively correlated with age, 
BMI and WHR, as did sexual fantasies with age and 
BMI. Sexual fantasies, erectile function and morning 
erections positively correlated with FTI. No correlations 
between sexual life parameters and other hormones 
were found, neither with lipids. Orgasmic function was 
not correlated with any studied parameters.
Discussion
Assessment of male sexual function has been the subject 
of intense research in recent years. As the incidence of 
sexual disorders increases with advancing age, most 
studies have been devoted to older men. However, 
the risk factors for cardiovascular disease, as well as 
decreased testosterone serum concentration, may ap-
pear early in life, even in prepubertal children [19]. It 
has been shown that one of these factors is increased 
body mass. Our previous study found that BMI and 
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WHR levels increase in men between the 20th and 40th 
year of life [4], and this fact was confirmed in the present 
study. Moreover, it was seen that the number of adverse 
risk factors for cardiovascular disease rapidly increases 
after 40. It was visible that after the 40th year of life, men 
had significantly worse lipid parameters (increased 
Table I. Results of hormonal determinations and serum levels of lipids in men between 20 and 49 years of age with normal 
body mass index (BMI < 25 kg/m2), overweight (BMI 25–29.9 kg/m2) and obesity (BMI ≥ 30 kg/m2)
Tabela I. Wyniki oznaczeń hormonalnych i lipidów we krwi mężczyzn w wieku 20–49 lat z prawidłową masą ciała (BMI < 
25 kg/m2), nadwagą (BMI 25–29,9 kg/m2) i otyłością (BMI ≥ 30 kg/m2)
Hormones  
and lipids
Age band (years)
20–29 30–39 40–49
BMI 
< 25  
kg/m2 
n = 28
BMI 
25–29.9  
kg/m2 
n = 10
BMI 
≥ 30  
kg/m2 
n = 6
BMI 
< 25  
kg/m2 
n = 13
BMI 
25–29.9  
kg/m2 
n = 17
BMI 
≥ 30  
kg/m2 
n = 6
BMI 
< 25  
kg/m2 
n = 26
BMI 
25–29.9  
kg/m2 
n = 22
BMI 
≥ 30  
kg/m2 
n = 8
LH 
[IU/L]
4.7 ± 1.6 4.6 ± 2.1 5.6 ± 1.3 4.5 ± 2.4 4.3 ± 1.5 3.6 ± 2.0 6.4 ± 2.5† 5.0 ± 1.9* 3.5 ± 0.9*
TT 
[nmol/L]
21.1 ± 6.6 18.2 ± 4.4 16.8 ± 3.7 20.0 ± 4.9 18.7 ± 5.3 14.4 ± 6.0* 19.0 ± 3.8 17.4 ± 6.2* 14.5 ± 4.1*
FTI 85.8 ± 30.2 84.9 ± 35.4 84.8 ± 22.0 74.1 ± 23.9† 63.0 ± 40.4 63.9 ± 19.9 47.7 ± 14.9† 45.7 ± 12.9 42.5 ± 12.2
DHEA-S 
[μg/dL]
271.6 ±  
109.7
297.2 ±  
106.2
289.0 ± 
 108.5
241.8 ±  
95.3†
258.2 ±  
102.3
263.8 ±  
91.9
227.1 ±  
84.5†
232.4 ±  
76.4
233.0 ±  
113.9
Oestradiol 
[pmol/L]
111.0 ± 47.4 125.1 ± 39.9 137.4 ± 37.3 95.4 ± 26.7 102.1 ± 44.4 107.8 ± 38.9 84.5 ± 28.8† 87.4 ± 12.2 92.9 ± 27.8
SHBG 
[nmol/L]
24.5 ± 8.9 23.8 ± 8.9 20.8 ± 6.9 28.9 ± 11.7 27.5 ± 13.8 26.9 ± 10.1 52.6 ± 21.3† 39.6 ± 16.9* 33.1 ± 10.1*
TC 
[mmol/L]
4.0 ± 1.0 4.3 ± 0.6 4.8 ± 0.7 4.5 ± 0.6 4.9 ± 1.2 5.3 ± 1.2 6.0 ± 0.9† 6.1 ± 0.9 6.3 ± 0.7
HDL-C 
[mmol/L]
1.5 ± 0.3 1.5 ± 0.4 1.3 ± 0.4 1.6 ± 0.3 1.4 ± 0.4 1.4 ± 0.5 1.7 ± 0.3† 1.6 ± 0.2 1.6 ± 0.2
LDL-C 
[mmol/L]
2.1 ± 0.9 2.3 ± 0.6 2.5 ± 0.6 2.3 ± 0.6 2.8 ± 0.9 3.2 ± 1.4 3.4 ± 1.3† 3.4 ± 1.2 3.5 ± 1.1
TG 
[mmol/L]
0.9 ± 0.4 1.0 ± 0.3 2.2 ± 1.2 1.2 ± 0.8 1.6 ± 1.3 2.0 ± 1.6 1.6 ± 0.8† 1.9 ± 1.2 2.3 ± 1.6
*p < 0.05 vs. BMI < 25 kg/m2 in each age band; †p<0.05 vs. BMI < 25 kg/m2 in 20-year-olds; Mann-Whitney U-test; n — number of subjects; LH — luteinising 
hormone; TT — total testosterone; FTI — free testosterone index; DHEA-S — dehydroepiandrosterone sulfate; SHBG — sex hormone binding globulin; TC — total 
cholesterol; HDL-C — HDL-cholesterol; LDL-C — LDL-cholesterol; TG — triglycerides
Table. II. Results (mean ± standard deviation scores) of sexual life assessment in men between 20 and 49 years of age with 
normal body mass index (BMI < 25 kg/m2), overweight (BMI 25–29.9 kg/m2) and obesity (BMI ≥ 30 kg/m2)
Tabela II. Wyniki (średnia ± odchylenie standardowe punktacji) oceny parametrów życia seksualnego u mężczyzn w wieku 
20–49 lat z prawidłową masą ciała (BMI < 25 kg/m2), nadwagą (BMI 25–29,9 kg/m2) i otyłością (BMI ≥ 30 kg/m2)
Parameters of 
sexual life
Age band (years)
20–29 30–39 40–49
BMI 
< 25  
kg/m2 
n = 28
BMI 
25–29.9  
kg/m2 
n = 10
BMI 
≥ 30  
kg/m2 
n = 6
BMI 
< 25  
kg/m2 
n = 13
BMI 
25–29.9  
kg/m2 
n = 17
BMI 
≥ 30  
kg/m2 
n = 6
BMI 
< 25  
kg/m2 
n = 26
BMI 
25–29.9  
kg/m2 
n = 22
BMI 
≥ 30  
kg/m2 
n = 8
Sexual fantasies 5.9 ± 1.4 5.3 ± 1.3 6.3 ± 1.6 6.3 ± 1.0 5.1 ± 1.3 6.4 ± 0.9 4.6 ± 1.2* 4.5 ± 1.9* 4.6 ± 1.5*
Erectile function 3.9 ± 0.5 3.6 ± 0.9 3.8 ± 0.4 3.8 ± 0.7 3.7 ± 0.5 3.8 ± 0.8 3.3 ± 0.6* 3.4 ± 0.6* 3.4 ± 0.5*
Morning erections 3.8 ± 1.3 3.3 ± 2.2 3.3 ± 2.9 3.2 ± 1.6 3.0 ± 2.3 3.0 ± 2.7 2.8 ± 1.9* 2.7 ± 1.3* 2.6 ± 1.8*
Orgasmic function 4.6 ± 1.2 4.7 ± 0.4 4.6 ± 0.5 4.4 ± 1.5 4.2 ± 1.3 4.2 ± 1.8 4.3 ± 1.3 4.3 ± 1.3 4.7 ± 0.5
* p < 0.05 vs. 20-year-old with BMI < 25 kg/m2, ANOVA Kruskal-Wallis test; n — number of subjects
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serum levels of TC, LDL-C and TG), but no correlation 
was found between serum concentration of lipids and 
BMI or WHR in each age group. Although other studies 
note that dyslipidaemia accompanies obesity and has 
been linked to ED in older men [20–22], it may be the 
case that the participants of our study were younger 
and in better health.
The present study reveals that TT and FTI declines, 
and SHBG increases, with age from the 30th year of life 
while the mean hormone levels remain within the physi-
ological range. Longitudinal studies in ageing males over 
40 report that the decline in free testosterone is caused 
by a rise in SHBG [9, 23, 24]. However, the results of the 
present study indicate that mean TT level is lower in 
men with excessive body weight compared to men with 
a normal BMI, even by the age of 30. In 40-year-olds, 
LH and SHBG levels were also found to be significantly 
lower. The same observation in older men has been 
made by several prospective studies [4, 9, 25, 26]. Wu et 
al. [9] observe that the effect of increasing BMI and waist 
size on circulating testosterone was more substantial 
than that of age. The change in BMI from non-obese to 
obese may be equivalent to a 15-year fall in TT. One pos-
sible explanation of this phenomenon may be a failure 
of the hypothalamus and/or pituitary to compensate 
for hypoandrogenaemia. Weight gain appears to lead 
to blunted LH secretion, but with unchanged serum 
levels. Moreover, obesity is associated with lower SHBG 
as a result of insulin resistance, with the high levels of 
circulating insulin inhibiting hepatic SHBG production 
[27, 28]. Camacho et al. [3] suggested that fluctuations 
in SHBG concentrations can provide metabolic signal-
linking variations to hypothalamo-pituitary-testicular 
axis function in adiposity, thereby regulating androgen 
bioactivity through insulin signalling. This is supported 
by the recent finding of Coviello et al. [29] that circulat-
ing SHBG is influenced by variations in genes involved 
in the regulation of lipid and carbohydrate metabolism. 
In addition, the delivery of bound hormones at target 
tissue sites is a further possibility of the active role played 
by SHBG in the regulation of sex steroid bioavailabil-
ity [30]. In addition to peripheral and central insulin 
resistance, obesity is associated with proinflammatory 
cytokine production (TNF-α and IL-6) from adipocytes 
and central nervous system endocannibinoid release, 
which can inhibit hypothalamo-pituitary-testicular axis 
function [31–33]. Increased plasma levels of leptin were 
found to be secreted from adipocytes in obese subjects. 
Leptin receptors are present in testicular Leydig cells 
and leptin may play a role in reduced androgen levels 
in obese men [34]. Lima et al. [35] found that massively 
obese men (BMI > 35 kg/m2) had consistently low free 
testosterone levels. The authors concluded that func-
tional decrease of LH pulse amplitude and serum LH 
levels, as well as the possible negative action of excess 
circulating leptin on steroidogenesis, may be related to 
the decreased androgen levels in obese men. In older 
men, multiple functional alterations in the action of 
reproductive hormones linked to distinct risk factors 
are shadowed by the progressive testicular impairment 
associated with increasing age [9]. In younger men, how-
ever, obesity may be the only risk factor for testosterone 
decline and poor sexual function. 
Obese men have been shown to have elevated circu-
lating levels of oestradiol predominantly derived from 
the aromatisation of circulating testosterone, mostly in 
adipose tissue where the enzyme aromatase is present 
in larger amounts [36]. The overall rate of aromatisa-
tion of testosterone to oestradiol increases with body 
mass. The non-significant trend for oestradiol serum 
level to increase with growing weight was also visible 
in our study. This phenomenon may result in a greater 
degree of testosterone deficiency by acting at the hy-
pothalamus to decrease GnRH pulse frequency, at the 
pituitary to decrease LH secretion, and at the testicular 
level to inhibit testosterone biosynthesis [37, 38]. It has 
been found that oestradiol serum levels show a positive 
cross-sectional relationship with age and depressed 
mood related to declining sexual function in ageing 
men [39]. However, the level of serum oestrogen in men 
has been also reported to decline with age [40], and our 
study revealed the same observation in young subjects. 
The results of the sexual parameter assessment, such 
as those concerning sexual fantasies, morning erec-
tions and erectile function, did not differ significantly 
between 20- and 30-year-old men. Only 40-year-olds 
showed significant deterioration of sexual function 
compared to 20-year-olds. General health worsened 
with age, but there were no serious diseases. Psychologi-
cal causes were of minor importance. There were also 
no differences associated with excessive body mass. In 
turn, significant correlations were found between the 
above mentioned sexual parameters and BMI or WHR. 
Table III. Results of significant Spearman’s correlation 
between parameters of sexual life and age, BMI, WHR, FTI 
in 136 men aged 20–49 years
Tabela III. Wyniki znamiennych statystycznie korelacji 
Spearmana pomiędzy parametrami życia seksualnego 
a wiekiem, BMI, WHR i FTI u 136 mężczyzn w wieku 20–49 lat
Parameters of 
sexual life
Age 
r
FTI 
r
BMI 
r
WHR 
r
Sexual fantasies –0.43* 0.28* –0.21* ns
Erectile function –0.34* 0.27* –0.20* –0.29*
Morning erections –0.25* 0.21* –0.22* –0.38*
*p < 0.05; r — Spearman’s correlation coefficient; FTI — free testosterone 
index; BMI — body mass index; WHR — waist to hip ratio; ns — not significant
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The results of our study are in agreement with 
other studies on cohorts of older men showing that 
several measures of obesity and central adiposity are 
significantly associated with ED prevalence [8, 41–43]. 
Orgasmic function was not correlated with any studied 
parameters. It is known that the incidence of OD is low 
(3–10% of men with sexual dysfunction) and increases 
with age [44–46]. Besides this, the pathophysiology of 
OD is not clear and needs more research. 
Obesity belongs to the group of modifiable factors 
which can be reduced or completely eliminated. Physi-
cal activity and a low-calorie diet allow weight loss, 
self-image improvement and better quality of life, as 
well as better sexual function and satisfaction [47–50]. 
There is, however, limited data as to whether reduction 
in body weight by itself would improve sexual function. 
In the Massachusetts Male Aging Study (MMAS), ten 
year follow up data suggested that obese men aged 
40 to 70, regardless of weight loss, had a greater risk 
of developing ED [51]. In turn, in a younger group of 
men (35–55 years) Esposito et al. [52] reported improve-
ment of erectile function after at least 10% weight loss, 
healthy diet and increased exercise. Moreover, results 
are emerging from randomised and observational stud-
ies demonstrating that lifestyle changes and weight 
loss are associated with better sexual function, even in 
individuals with diabetes mellitus and in older men [46, 
53, 54], which may be the result of increased testoster-
one levels. Camacho et al. [3] showed that weight gain 
was associated with suppression of TT, free testosterone 
and SHBG, while weight loss was associated with an 
increase in TT, free testosterone, SHBG and LH in men 
taking part in EMAS. Possible explanations for the dif-
ference between older and younger men with regard 
to the responsiveness of erectile function to weight loss 
include increased prevalence of cardiovascular disease, 
fewer urinary tract disorders, and other comorbidities 
at older ages. Corona et al. [55] revealed that more 
than 50% of EMAS subjects reported the presence of 
one or more common morbidities. Around 30% of 
men reported ED and 6% reported severe OD, both of 
which were closely associated with age and concomi-
tant morbidities. Hence, sexual health declined while 
concomitant morbidities increased as a function of age. 
Conclusions
The general increase in obesity among men may result 
in more individuals with sexual dysfunction. ED in 
older men is the result of the decrease in testosterone 
and increase in SHBG serum levels. Obesity by itself 
may enhance the decline of testosterone but also repre-
sents a severe risk of cardiovascular disease and diabetes 
mellitus, which are also risk factors of ED. In younger 
men, excessive weight is not a reason for comorbidities, 
but may be the cause of lower testosterone action lead-
ing to worse sexual function in men over 40. Obesity 
is a reversible phenomenon. Hence, it is important to 
undertake preventive action in young people to reduce 
excessive weight and, in this way, reduce the risk of 
further sexual dysfunction.
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